Criteria for paediatric oral liquid form

Article Sidebar

PDF HTML
Submitted: March 18, 2021
Published: Mar 26, 2021
DOI: 10.29328/journal.apps.1001026

Main Article Content

Daniela Gavrus
Servei de Farmàcia Hospital Sant Joan de Déu, Spain
Ferran Bossacoma Busquets
Servei de Farmàcia Hospital Sant Joan de Déu, Spain
Josep Maria Català
Servei de Farmàcia Hospital Sant Joan de Déu, Spain
Joan Lluis Vinent Genestar
Servei de Farmàcia Hospital Sant Joan de Déu, Spain
Miquel Villaronga Flaque
Servei de Farmàcia Hospital Sant Joan de Déu, Spain

Article Details

Gavrus, D., Busquets, F. B., Català, J. M., Genestar, J. L. V., & Flaque, M. V. (2021). Criteria for paediatric oral liquid form. Archives of Pharmacy and Pharmaceutical Sciences, 5(1), 018–019. https://doi.org/10.29328/journal.apps.1001026
Letter to Editor

Copyright (c) 2021 Gavrus D, et al.

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

Ceci A, Felisi M, Baiardi P, Bonifazi F, Catapano M, et al. Medicines for children licensed by the European Medicines Agency (EMEA): the balance after 10 years. Eur J Clin Pharmacol. 2006; 62: 947–952. PubMed: https://pubmed.ncbi.nlm.nih.gov/17021892/

Regulation (EC) No 1901/2006 of the European Parliament and of the Councilof 12 Decembre 2006 on medicinal products for Paediatric use, OJ L 2006; 378:1. https://ec.europa.eu/health/sites/health/files/files/eudralex/vol-1/reg_2006_1901/reg_2006_1901_en.pdf

World Health Organization. Annex 5. Development of paediatric medicines: points to consider in formulation. World Health Organ Tech Rep Ser. 2012; 970: 197–225. http://apps.who.int/medicinedocs/documents/s19833en/s19833en.pdf

European Medicines Agency . 10-year report to the European commission – General report on the experience acquired as a result of the application of the Paediatric Regulation. 2016. EMA/231225/2015 . https://ec.europa.eu/health/sites/health/files/files/paediatrics/2016_pc_report_2017/ema_10_year_report_for_consultation.pdf

Fabiano V, Mameli C, Zuccotti GV. Paediatric pharmacology: remember the excipients. Pharmacol Res. 2011; 63: 362–365. PubMed: https://pubmed.ncbi.nlm.nih.gov/21241804/

Breikreutz J, Boos J. Paediatric and geriatric drug delivery. Expert Opin Drug Deliv. 2007; 4: 37-45. PubMed: https://pubmed.ncbi.nlm.nih.gov/17184161/

European Commission. Annex to the European Commission guideline on ‘Excipients in the labelling and package leaflet of medicinal products for human use’ (SANTE-2017-11668). 2017. https://www.ema.europa.eu/documents/scientific-guideline/annex-european-commission-guideline-excipients-labelling-package-leaflet-medicinal-products-human_en.pdf

European Medicines Agency. Guideline on pharmaceutical development of medicines for paediatric use. EMA. Rev. 2. 2012. https://www.ema.europa.eu/documents/scientific-guideline/draft-guideline-pharmaceutical-development-medicines-paediatric-use_en.pdf

Billstein-Leber M, D Carrillo CJ, Cassano AT, Moline K, Robertson JJ. ASHP Guidelines on Preventing Medication Errors in Hospitals. Am J Health-Syst Pharm. 2018; 75: 1493-517. PubMed: https://pubmed.ncbi.nlm.nih.gov/30257844/

Ivanovska V, Rademaker CMA, van Dijk L, Mantel-Teeuwisse AK. Pediatric Drug Formulations: A Review of Challenges and Progress. Paediatrics. 2014; 134: 361-372. PubMed: https://pubmed.ncbi.nlm.nih.gov/25022739/